Fosaprepitant-induced Phlebitis: A Focus on Patients receiving Doxorubicin/Cyclophosphamide therapy

PURPOSE: The purpose of this study was to investigate the incidence of fosaprepitant-associated infusion site adverse events (ISAEs) among a cohort of breast cancer patients receiving doxorubicin/cyclophosphamide (AC) chemotherapy. METHODS: A retrospective review of electronic medical record (EMR) d...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Leal, A. D., Kadakia, K. C., Looker, S., Hilger, C., Sorgatz, K., Anderson, K., Jacobson, A., Grendahl, D., Seisler, D., Hobday, T., Loprinzi, C. L.
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3969765/
https://ncbi.nlm.nih.gov/pubmed/24402411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-013-2089-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires